My group's research focusses on developing and applying chemistry for molecular imaging and systemic targeted radiotherapy. We are particularly interested in incorporating radioactive metals into biomolecules that target cell-surface receptors of cancer cells. These radiolabelled biomolecules enable whole body diagnostic molecular imaging of cancer using PET or SPECT imaging, or alternatively, deliver a cytotoxic/radiotherapeutic dose of radiation to diseased cells.

Our research spans basic chemical research (chelator synthesis, inorganic chemistry, radiochemistry), application of new and existing chemistry to develop new radiolabelled agents, and preclinical research in which we test new radiolabelled agents in biological models of disease. We collaborate with a range of academic, industry and clinical partners.